|
SF-36 scores (higher scores indicate less impairment). |
||||||||
| Baseline |
SAMe |
Celecoxib |
||||||
|
|
||||||||
| Variable |
N+ |
Mean |
(SD) |
Mean |
(SD) |
Mean |
(SD) |
Stdif. |
|
|
||||||||
| Physical Function |
53 |
52.5 |
(20.8) |
62.4* |
(22.8) |
63.7* |
(25.1) |
-0.10 |
| Role Physical |
53 |
56.6 |
(37.4) |
66.5* |
(33.6) |
67.9* |
(38.1) |
-0.04 |
| Role Emotional |
53 |
86.8 |
(29.5) |
88.7 |
(24.4) |
87.4 |
(27.1) |
0.06 |
| Vitality |
53 |
58.9 |
(14.4) |
60.4 |
(14.0) |
62.9* |
(14.5) |
-0.23 |
| Mental Health |
53 |
71.8 |
(11.4) |
73.7 |
(11.3) |
74.0 |
(11.8) |
-0.03 |
| Social Function |
53 |
82.3 |
(20.1) |
84.2 |
(19.8) |
86.3 |
(18.7) |
-0.09 |
| Bodily Pain |
53 |
46.8 |
(14.1) |
59.3* |
(19.8) |
63.1* |
(19.6) |
-0.16 |
| General Health |
53 |
74.6 |
(15.2) |
75.4 |
(17.2) |
76.6 |
(16.8) |
-0.10 |
| General Physical |
53 |
38.1 |
(8.2) |
42.3* |
(9.5) |
43.4* |
(10.6) |
-0.16 |
| General Mental |
53 |
54.6 |
(7.8) |
54.1 |
(7.4) |
54.2 |
(6.8) |
-0.02 |
|
Stdif: Standardized difference scores – positive numbers indicate a better response with SAMe. +Sample sizes are less than 57 due to missing data in either Phase 1 or Phase 2. *Difference between baseline and treatment is statistically significant (p < 0.05). No statistically significant differences were observed between SAMe and Celecoxib. | ||||||||
Najm et al. BMC Musculoskeletal Disorders 2004 5:6 doi:10.1186/1471-2474-5-6 |
||||||||